Guangzhou Baiyunshan (Germany) Today
| GU5 Stock | EUR 2.16 0.02 0.92% |
Performance12 of 100
| Odds Of DistressLess than 9
|
Guangzhou Baiyunshan is trading at 2.16 as of the 12th of December 2024. This is a 0.92 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.16. Guangzhou Baiyunshan has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 13th of September 2024 and ending today, the 12th of December 2024. Click here to learn more.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the Peoples Republic of China and internationally. The company has 219.9 M outstanding shares. More on Guangzhou Baiyunshan Pharmaceutical
Moving against Guangzhou Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Guangzhou Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Guangzhou Baiyunshan's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Guangzhou Baiyunshan or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Chuyuan Li |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Guangzhou Baiyunshan Pharmaceutical (GU5) is traded on Frankfurt Exchange in Germany and employs 25,437 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Guangzhou Baiyunshan's market, we take the total number of its shares issued and multiply it by Guangzhou Baiyunshan's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Guangzhou Baiyunshan classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 219.9 M outstanding shares.
Guangzhou Baiyunshan Pharmaceutical has accumulated about 21.69 B in cash with 5.67 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Guangzhou Baiyunshan Probability Of Bankruptcy
Ownership AllocationGuangzhou Baiyunshan secures a total of 219.9 Million outstanding shares. 30% of Guangzhou Baiyunshan outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Guangzhou Ownership Details
Guangzhou Baiyunshan Risk Profiles
Although Guangzhou Baiyunshan's alpha and beta are two of the key measurements used to evaluate Guangzhou Baiyunshan's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.01 | |||
| Semi Deviation | 1.91 | |||
| Standard Deviation | 3.4 | |||
| Variance | 11.59 |
Guangzhou Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Guangzhou Baiyunshan without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Guangzhou Baiyunshan Corporate Directors
| Xiaoping Chu | Independent Director | Profile | |
| Changhai Wu | Executive Deputy General Manager, Executive Director | Profile | |
| Weihong Wang | Independent Director | Profile | |
| Chunbo Zhang | Deputy General Manager, Executive Director | Profile |
Other Information on Investing in Guangzhou Stock
Guangzhou Baiyunshan financial ratios help investors to determine whether Guangzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guangzhou with respect to the benefits of owning Guangzhou Baiyunshan security.